Histopathologically confirmed HER2-positive invasive breast cancer; Clinical staging of disease classified as T2N0M0.
You may not be if
Patients who have undergone chemotherapy, endocrine therapy, targeted therapy, or radiotherapy for this condition; Due to severe and uncontrolled medical conditions, the investigator deems chemotherapy contraindicated.
Clareo Health | De-escalation Neoadjuvant Therapy for Intermediate Risk HER2-positive Early Breast
